Details

Written by Eliezer Masliah, M.D.

Agency: NIH/NIMH

Agency Award Number: R01MH062962

To investigate the role of alterations in CDK5 signaling pathway in the molecular mechanisms of synapto-dendritic damage triggered by HIV proteins, and to determine the involvement of the CDK5 signaling pathway in the mechanisms of defective neurogenesis triggered by HIV proteins.

Details

Written by Igor Grant, M.D.

Agency: NIH/NIDA

Agency Award Number: Suppl

To examine whether active METH use during the acute phase of HIV infection worsens the depletion of gut-associated lymphocyte tissue (GALT) and therefore increases the risk of micorbial translocation, inflammatory response, and neurocognitive impairment.

Details

Written by David J. Moore, Ph.D.

Agency: NIH/NIMH
Agency Award Number: R03

To determine if there are differences between the medication adherence abilities of persons with co-occurring bipolar disorder and HIV infection as compared to those with HIV infection alone, and to assess the predictors of nonadherence in these groups.

Details

Written by Erick Tatro, Ph.D.

Agency: NIH/HNRC
Agency Award Number: HNRC869

To create a genome-wide microRNA profile in the HIV-infected human frontal cortex and cingulate gyrus.